Login / Signup
Specific elimination of coxsackievirus B3 infected cells with a protein engineered toxin-antitoxin system.
Jung-Ho Park
Jin-Ho Park
Wonho Choi
Byung-Kwan Lim
Published in:
Molecular & cellular toxicology (2019)
These findings suggest that the MazEF fusion protein has a strong potential to be developed as an anti-virus therapy following CVB3 infection.
Keyphrases
</>
induced apoptosis
escherichia coli
cell cycle arrest
endoplasmic reticulum stress
stem cells
binding protein
signaling pathway
cell death
amino acid
mesenchymal stem cells
risk assessment
cell therapy